Hawthorne Effect

#healthcare company, transforming #patientexperience with follow-up, creating greater opportunities for #participants and stakeholders of #clinicaltrials

[Hawthorne Effect @Hawthorne_ACTs]

Our partnership with CRF is changing the industry standard for inclusiveness in clinical trials! Thank you to @OutsourcPharma & @Liza77Laws for highlighting the new bar the Prevue-Valve study is setting for diverse patient recruitment.
https://t.co/zg5oZn2qoR

[Hawthorne Effect @Hawthorne_ACTs]

https://t.co/aB3UF9C9tL

We're very thankful to @steven_aquino and @Forbes for their highlight of our Founder + CEO Jodi Akin, not to mention Hawthorne's efforts to make clinical trials available to all!

[Hawthorne Effect @Hawthorne_ACTs]

Thanks to @FoleyandLardner for hosting Jodi on the Health Care Law Today Podcast! https://t.co/q4jxk8Utp5

[Hawthorne Effect @Hawthorne_ACTs]

On #clinicaltrialsday, we want to celebrate and give thanks to the amazing healthcare pros, sponsors, and patients who make #clinicalresearch happen. Moreover, we want to say it loud and clear: the impact of your work is immediate and unmistakable. https://t.co/LUGh8ogJwg

[Hawthorne Effect @Hawthorne_ACTs]

We're happy to celebrate International Women's Day and #EmbraceEquity. Our Founder + CEO Jodi Akin started Hawthorne Effect in large part to increase diversity in #clinicaltrials, and equity and diversity are critical to all of #clinicalresearch and healthcare.

[Hawthorne Effect @Hawthorne_ACTs]

Day two of #acc23! Great crowds and conversations yesterday.

[Hawthorne Effect @Hawthorne_ACTs]

Hawthorne Heroes get to participate in world-class research by bringing clinical trials directly to patients, and that often results in incredible stories. Here's Hero Julie Dunn talking about one of her favorite #clinicaltrials experiences. https://t.co/uw2ylDGCBQ

[Hawthorne Effect @Hawthorne_ACTs]

If you're headed to New Orleans next weekend for #ACC2023, make sure to stop by Booth 410 and say hello to the Hawthorne Effect team! We're excited to talk about #clinicaltrials at one of the best gatherings for cardiologists and heart specialists. https://t.co/FxYe2sXAkm

[Hawthorne Effect @Hawthorne_ACTs]

Third day of #SCOPE2023! Yesterday's Venture, Innovation, & Partnering Conference was amazing, and there are still so many great panels to come. #scopesummit #patientaccess

[Hawthorne Effect @Hawthorne_ACTs]

So exciting to see Hawthorne Effect Founder + CEO Jodi Akin live at #scopesummit! #clinicaltrials

[Hawthorne Effect @Hawthorne_ACTs]

Great #scopesummit panel on bridging the chasm of research and care. We touched on this very subject not long ago: https://t.co/S9alfCHMad. #clinicaltrials #dct

[Hawthorne Effect @Hawthorne_ACTs]

"History teaches us that disruptive market transformations take 10 years on average ... I believe that we are around the 7-year moment of that transformation arc" says Jodi Akin re: democratization of #clinicaltrials. More to come from #scopesummit. https://t.co/3xYAAaeM9i

[Hawthorne Effect @Hawthorne_ACTs]

Tech is only one part of aligning #clinicalresearch and consumer healthcare - a solution still requires people. HE's Jodi Akin will elaborate on this as co-chair of the SCOPE Venture, Innovation & Partnering Conference, but here's a preview: https://t.co/S9alfCHMad #scopesummit

[Hawthorne Effect @Hawthorne_ACTs]

Diversity in #clinicaltrials is important, and more remains to be done for inclusivity. But what are the implications when we consider specific research areas like cardiovascular? Heart disease is still our #1 killer, so we're digging into it. https://t.co/G40Mp0KPjp

[Hawthorne Effect @Hawthorne_ACTs]

Is anyone attending the 2023 SCOPE Summit (2/6-2/9) in Orlando? Hawthorne Effect Founder + CEO Jodi Akin is co-chairing the Venture, Innovation, & Partnering Conference on 2/7 that brings together innovation and investment in #clinicaltrials. #scopesummit https://t.co/MTChPnS2s2

[Hawthorne Effect @Hawthorne_ACTs]

Elevation of #clinicaltrials in consumer care and a revolution in site models point the way forward for deliberate change in clinical research, says Hawthorne Effect Founder + CEO Jodi Akin. It's time to move beyond #decentralizedtrials. https://t.co/WqP2IDO857

[Hawthorne Effect @Hawthorne_ACTs]

Elevation of #clinicaltrials in consumer care and a revolution in site models point the way forward in clinical research, says Hawthorne Effect Founder + CEO Jodi Akin. It's time to go beyond #decentralizedtrials. https://t.co/WqP2IDO857

[Hawthorne Effect @Hawthorne_ACTs]

If you're not already subscribed to the Before We Die podcast, tune in on December 27 to catch Hawthorne Effect Founder + CEO Jodi Akin talk about democratization of clinical research in a post-pandemic world: https://t.co/LRx6BAWlVi #clinicaltrials #patiententricity

[Hawthorne Effect @Hawthorne_ACTs]

If you're not already subscribed to the Before We Die podcast, tune in on December 27 to catch Hawthorne Effect Founder + CEO Jodi Akin talk about democratization of clinical research in a post-pandemic world: https://t.co/LRx6BAWlVi #clinicaltrials #patientcentricity

[Hawthorne Effect @Hawthorne_ACTs]

How does one tell DCT companies apart? Great post from Kate Flathers, our Head of Product, tackling this important question. Short spoiler: it's about moving beyond DCT and addressing patient-centricity. https://t.co/WeHczFP0Qf #dct #clinicalresearch